These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner. Roberts ME; Epstein BJ J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098 [TBL] [Abstract][Full Text] [Related]
5. Issues in blood pressure control and the potential role of single-pill combination therapies. Burnier M; Brown RE; Ong SH; Keskinaslan A; Khan ZM Int J Clin Pract; 2009 May; 63(5):790-8. PubMed ID: 19220523 [TBL] [Abstract][Full Text] [Related]
6. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy. Epstein M; Bakris G Arch Intern Med; 1996 Sep; 156(17):1969-78. PubMed ID: 8823150 [TBL] [Abstract][Full Text] [Related]
7. Management of hypertension with fixed-dose triple-combination treatments. Epstein BJ; Shah NK; Borja-Hart NL Ther Adv Cardiovasc Dis; 2013 Oct; 7(5):246-59. PubMed ID: 23945906 [TBL] [Abstract][Full Text] [Related]
8. Fixed-dose triple-combination treatments in the management of hypertension. Ram CV Manag Care; 2013 Dec; 22(12):45-55. PubMed ID: 24555265 [TBL] [Abstract][Full Text] [Related]
9. Optimizing the Management of Uncontrolled Hypertension: What do Triple Fixed-Dose Drug Combinations Add? Thomopoulos C; Katsimagklis G; Archontakis S; Skalis G; Makris T Curr Vasc Pharmacol; 2017; 16(1):61-65. PubMed ID: 28413969 [TBL] [Abstract][Full Text] [Related]
10. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide. Abe M; Okada K; Matsumoto K Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of recent fixed-dose combination therapies in the management of hypertension. Khanna A; Lefkowitz L; White WB Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):477-83. PubMed ID: 18695388 [TBL] [Abstract][Full Text] [Related]
12. [Calcium antagonists: current and future applications based on new evidence. Calcium channel blockers and single-pill combination]. Okura T; Higaki J Clin Calcium; 2010 Jan; 20(1):61-8. PubMed ID: 20048435 [TBL] [Abstract][Full Text] [Related]
13. Rationale for the use of very-low-dose combinations as first-line treatment of hypertension. Waeber B; Brunner HR J Hypertens Suppl; 2001 Nov; 19(4):S3-8. PubMed ID: 11848261 [TBL] [Abstract][Full Text] [Related]
16. Single-pill combination of amlodipine and valsartan in the management of hypertension. Flack JM; Hilkert R Expert Opin Pharmacother; 2009 Aug; 10(12):1979-94. PubMed ID: 19606937 [TBL] [Abstract][Full Text] [Related]
17. Use of single-pill combination therapy in the evolving paradigm of hypertension management. Calhoun DA Expert Opin Pharmacother; 2009 Aug; 10(12):1869-74. PubMed ID: 19496740 [TBL] [Abstract][Full Text] [Related]
18. Initial combination therapy for rapid and effective control of moderate and severe hypertension. Franklin SS; Neutel JM J Hum Hypertens; 2009 Jan; 23(1):4-11. PubMed ID: 18615100 [TBL] [Abstract][Full Text] [Related]
19. [Hypertension combination therapy with renin-angiotensin system blockers]. Soucek M Vnitr Lek; 2009 Sep; 55(9):719-23. PubMed ID: 19785368 [TBL] [Abstract][Full Text] [Related]
20. [The combination of an ACE inhibitor and a calcium channel blocker is an optimal combination for the treatment of hypertension]. Widimský J Vnitr Lek; 2009 Feb; 55(2):123-30. PubMed ID: 19348394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]